Example: Heart Attack

Search clinical trials for: 3,4-diaminopyridine

Total 10 results

  • NCT03062631
    Available
    Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome
    Conditions: Congenital Myasthenic Syndrome, Lambert-Eaton Myasthenic Syndrome
  • NCT02012933
    No longer available
    3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
    Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenia (CM)
  • NCT01765140
    No longer available
    Treatment Use of 3,4-Diaminopyridine
    Conditions: Myasthenic Syndromes, Congenital
  • NCT01441557
    Completed
    Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism
    Conditions: Botulism
  • NCT01378546
    No longer available
    Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
    Conditions: Lambert Eaton Myasthenic Syndrome (LEMS)
  • NCT00994916
    No longer available
    Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
    Conditions: Lambert-Eaton Myasthenic Syndrome
  • NCT00872950
    Active, not recruiting
    3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
    Conditions: Lambert-Eaton Myasthenic Syndrome, Congenital Myasthenic Syndrome
  • NCT00190268
    Completed
    Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis
    Conditions: Multiple Sclerosis
  • NCT00004832
    Completed
    Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
    Conditions: Lambert-Eaton Myasthenic Syndrome
  • NCT00342381
    Completed
    Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
    Conditions: Multiple Sclerosis, Fatigue
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations